Key result
A 5-gene signature based on lipid metabolism (TM4SF1, KCNK5, FASN, IMPDH1, and KCNJ15) was established as an independent prognostic indicator for bladder cancer.
Why the study?
Dysregulation of lipid metabolism is considered a major risk factor for bladder cancer, prompting the screening of lipid metabolism-related genes to predict prognosis.
A novel 5-gene signature based on lipid metabolism was established as an effective prognostic indicator for bladder cancer.
Answers are grounded in this paper and cite their sources.
Lipid metabolism signatures may refine bladder cancer prognostication; hypothesis-generating and requires prospective validation before clinical use.
Background. Aberrant lipid metabolism is an alteration common to many types of cancer. Dysregulation of lipid metabolism is considered a major risk factor for bladder cancer. Accordingly, we focused on genes related to lipid metabolism and screened novel markers for predicting the prognosis of bladder cancer. Methods. RNA‐seq data for bladder cancer were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The nonnegative matrix factorization (NMF) algorithm was used to classify the molecular subtypes. Weighted correlation network analysis (WGCNA) was applied to identify coexpressed genes, and least absolute shrinkage and selection operator (LASSO) multivariate Cox analysis was used to construct a prognostic risk model. External validation data and in vitro experiments were used to verify the results from in silico analysis. Results. Bladder cancer samples were grouped into two clusters based on the NMF algorithm. A total of 1467 genes involved in coexpression modules were identified in WGCNA. We finally established a 5‐gene signature (TM4SF1, KCNK5, FASN, IMPDH1, and KCNJ15) that exhibited good stability across different datasets and was also an independent risk factor for prognosis. Furthermore, the predictive efficacy of our model was generally higher than the predictive efficacy of other published models. Distinct risk groups of patients also showed significantly different immune infiltration cell patterns and associations with clinical variables. Moreover, the 5 signature genes were verified in clinical samples by quantitative real‐time polymerase chain reaction (qRT‐PCR) and immunohistochemistry, which were in agreement with the in silico analysis. For in vitro experiments, knockdown of IMPDH1 markedly inhibited cell proliferation in bladder cancer. Conclusion. We established a 5‐gene prognosis signature based on lipid metabolism in bladder cancer, which could be an effective prognostic indicator.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2022) studied Bladder cancer. 5-gene signature (TM4SF1, KCNK5, FASN, IMPDH1, and KCNJ15) was evaluated on Prognosis. A 5-gene signature based on lipid metabolism (TM4SF1, KCNK5, FASN, IMPDH1, and KCNJ15) was established as an independent prognostic indicator for bladder cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: